Trial Profile
A Double-masked, Crossover Study Assessing the Ocular and Systemic Safety and Systemic Absorption of Two Formulations of 0.5% AR-12286 Ophthalmic Solution in Normal Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2014
Price :
$35
*
At a glance
- Drugs Verosudil (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Aerie Pharmaceuticals
- 05 May 2014 New trial record